Mural Oncology plc

Contributing Author

Recent Articles by Mural Oncology plc

Oct-24	Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty MURA GlobeNewswire
Sep-23	Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting MURA GlobeNewswire
Aug-20	Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share MURA GlobeNewswire
Aug-04	Mural Oncology Announces Second Quarter Financial Results and Provides Business Update MURA GlobeNewswire
May-19	Mural Oncology Announces Number of Relevant Securities in Issue MURA GlobeNewswire